Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Microbiology (Reading, England)|October 3, 2003
Transcript map of the temperate Lactobacillus gasseri bacteriophage phiadhEric Altermann, Bernhard Henrich
Antimicrobial Agents and Chemotherapy|March 11, 2009
An ABC transporter of Streptococcus pneumoniae involved in susceptibility to vancoresmycin and bacitracinPetra Becker, Regine Hakenbeck, Bernhard Henrich
The EPMA Journal|December 4, 2012
Proliferative diabetic retinopathy: predictive and preventive measures at hypoxia induced retinal changesTatjana Josifova, Ivna Plestina-Borjan, Paul Bernhard Henrich
Applied and Environmental Microbiology|July 31, 2002
Inducible promoter-repressor system from the Lactobacillus casei phage phiFSWBernhard Binishofer, Isabella Moll, Bernhard Henrich, et al.
Microbiology (Reading, England)|December 10, 1999
PepR1, a CcpA-like transcription regulator of Lactobacillus delbrueckii subsp. lactisJoachim Schick, Beate Weber, Jürgen R Klein, et al.
The Open Ophthalmology Journal|June 21, 2014
Clinical risk factors for poor anatomic response to ranibizumab in neovascular age-related macular degenerationJosef Guber, Tatjana Josifova, Paul Bernhard Henrich, et al.
European Journal of Ophthalmology|October 15, 2016
Comparing ranibizumab monotherapy and combination with single photodynamic therapy in wet AMD: retreatment and morphologic resultsKatja Hatz, Ulrike Schneider, Bernhard Henrich, et al.
BMC Microbiology|January 22, 2014
Altered lipid composition in Streptococcus pneumoniae cpoA mutantsMarina Meiers, Carsten Volz, Jessica Eisel, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|December 5, 2014
Ranibizumab plus verteporfin photodynamic therapy in neovascular age-related macular degeneration: 12 months of retreatment and vision outcomes from a randomized studyKatja Hatz, Ulrike Schneider, P Bernhard Henrich, et al.
Pageof 3